Tactiva Therapeutics is fighting cancer by developing “Next Generation” adoptive cell therapy (ACT) strategies that deliver lethal hits to cancer cells. Their approach provides robust and sustained immune attack on tumors by infusing large numbers of patients’ own T cells that have been re-programed to recognize, attack and destroy cancer cells.